EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

 ISSN (O) : 2394-3211

 ISSN (P) : 3051-2573

Impact Factor: 8.158

 ICV - 79.57

Abstract

PHARMACEUTICAL INDUSTRY PARTNERSHIPS AND PRESCRIBING PRACTICES IN MALI: A MIXED-METHODS STUDY OF INFLUENCE ON CLINICAL DECISIONS AND CARE PROTOCOLS

Amadou Alimam Cissé MSc, Abdoulaye Diawara PhD*, Hamadoun Garba PhD, Mariam Drame PhD, Talib Yussef Abbas PhD, Issa Coulibaly PhD, Yeya dit Sadio Sarro PhD, Kassoum Kayentao PhD,

ABSTRACT

Objectives: To assess how pharmaceutical industry partnerships influence prescribing practices and the development of clinical care protocols in Mali, where out-of-pocket health expenditures reach nearly 40% of total health spending. Methods: We conducted a sequential mixed-methods study from January to December 2026 in Commune III of Bamako. The quantitative phase surveyed 331 health professionals, 90 patients, and 94 pharmaceutical industry representatives using electronic questionnaires. The qualitative phase involved semi-structured interviews with protocol drafters and health decisionmakers. We used descriptive statistics, Spearman correlations, and multivariate regressions to analyze associations between industry exposure and prescribing outcomes. Results: Partnerships were intense and nearly universal. All professionals (100%) reported receiving promotional gifts, 87.3% received free samples, and 52.9% received offered meals. Medical representatives averaged 17.4 professional contacts per day. Brand-name prescribing dominated: professionals prescribed brand-name specialties in 73.2% of prescriptions on average, and 68.7% did so in 7 or more of every 10 prescriptions (Figure 1). We found no significant correlation between industry exposure score and brand-name prescribing (r = 0.13; P = .535). Being a physician was the only factor significantly associated with increased brand-name prescribing (β = 1.57; P < .001; Table 1). All patients (100%) were aware of medical representatives' influence, and 42.2% had forgone care because of cost (Table 2). One-third of protocol drafters considered industry participation in guideline development unacceptable. Conclusions: Pharmaceutical partnerships in Mali are intense and coexist with high rates of brand-name prescribing an indicator of irrational prescribing. Although exposure to industry benefits was not directly correlated with brand-name prescribing in this study, the normalization of these practices and their financial impact on patients demand urgent, context-adapted regulation.

Keywords: Pharmaceutical industry, prescribing, Mali, conflicts of interest, care protocols, public health.


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

LOGIN333

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 October 2026 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: OCTOBER ISSUE PUBLISHED

    OCTOBER 2026 issue has been successfully launched on 1 OCTOBER 2026.

  • EJPMR: New Impact Factor 2026

    EJPMR Impact Factor has been Increased from 7.065 to 8.158, for Year 2026

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia Doi-Digital Online Identifier ISSN National Centre Zenodo Indexing International CODEN Service, USA

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along witcertificate to promote resear activity of scholar.

Best Article of current issue :

Dr. Kartik Neog
Download Article : Click here